SAN DIEGO, July 15, 2019 /PRNewswire/ -- Shareholder Rights
Law Firm Johnson Fistel, LLP is investigating potential violations
of federal and state laws by Diplomat Pharmacy, Inc.
("Diplomat") (NYSE: DPLO) and certain of its officers.
Earlier in 2019 a securities class action lawsuit was filed on
behalf of purchasers of the securities of Diplomat from
February 26, 2018 through
February 21, 2019, (the "Class
Period"). The complaint alleges that defendants made false and
misleading statements and failed to disclose that: (1) Diplomat had
downplayed its success in integrating and growing its PBM business,
which included LDI Integrated and National Pharmaceutical, two
companies Diplomat had acquired in late 2017; (2) consequently,
Diplomat would need to record a non-cash impairment charge upwards
of approximately $630 million
relating to its PBM business and these 2017 acquisitions; (3) due
to the foregoing, Diplomat would withdraw its preliminary 2019
full-year outlook issued less than seven weeks prior; and (4) as a
result, defendants' statements about Diplomat's business,
operations and prospects were materially false and misleading and
lacked a reasonable basis at all relevant times.
If you are a shareholder of Diplomat, you may have
standing to hold Diplomat harmless from the alleged harm caused by
the officers and directors of the Company.
If you have information that could assist in this
investigation, including past employees and others, or if you are
an Diplomat shareholder and are interested in learning more about
the investigation or your legal rights and remedies, please contact
Jim Baker
(jimb@johnsonfistel.com) by email or phone at 619-814-4471. If
emailing, please include a phone number.
Additionally, you can [click here to join this
action]. There is no cost or obligation to you.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York, and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonfistel.com. Attorney advertising. Past results do
not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
[click here to join this action].
View original
content:http://www.prnewswire.com/news-releases/dplo-alert-johnson-fistel-llp-announces-investigation-of-diplomat-pharmacy-inc-long-term-investors-encouraged-to-contact-firm-300884789.html
SOURCE Johnson Fistel, LLP